Label: CONVERTHERA NAD PLUS PATCH patch

  • NDC Code(s): 85945-0001-1, 85945-0001-2
  • Packager: Through Medical INC.
  • Category: HUMAN OTC DRUG LABEL

DISCLAIMER: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. For further information about unapproved drugs, click here.

Drug Label Information

Updated July 18, 2025

If you are a healthcare professional or from the pharmaceutical industry please visit this version.

View All Sections
  • DOSAGE & ADMINISTRATION

    Apply the patch to skin firmly.
    Leave on for 4-6 hours, then remove and discard.
    Use 1-2 patches per week as needed or as directed by a licensed provider.

  • WARNINGS

    Warnings:
    For external use only. Do not exceed the recom- mended dose. Do not apply to broken, irritated, or sensitive skin. Mild redness or tingling may occur and is considered normal. Discontinue use if irritation or rash develops. Pregnant or nursing mothers, children under 18, or individu- als with known medical conditions should consult a physician before use. KEEP OUT OF REACH OF CHILDREN. DO NOT USE IF SAFETY SEAL IS DAMAGED OR MISSING. STORE IN A COOL, DRY PLACE.

  • INACTIVE INGREDIENT

    Other Ingredients: Transdermal patch layer with hydrogel matrix and backing film.

  • INDICATIONS & USAGE

    Clean a dry, hair-free area (upper arm, abdomen, or back).
    Add 8-10 drops of NAD+ solution to the patch.
    Apply the patch to skin firmly.
    Leave on for 4-6 hours, then remove and discard.

  • KEEP OUT OF REACH OF CHILDREN

    KEEP OUT OF REACH OF CHILDREN.

  • ACTIVE INGREDIENT

    NAD+
    (Nicotinamide Adenine
    250 mg

    Dinucleotide)
    Vitamin B12
    15,000 mcg

    Glutathione

  • PURPOSE

    Use 1-2 patches per week as needed or as directed by a licensed provider.

  • PRINCIPAL DISPLAY PANEL

    Content of LabelingLabeling

  • INGREDIENTS AND APPEARANCE
    CONVERTHERA NAD PLUS PATCH 
    converthera nad plus patch patch
    Product Information
    Product TypeHUMAN OTC DRUGItem Code (Source)NDC:85945-0001
    Route of AdministrationTRANSDERMAL
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    NICOTINAMIDE ADENINE DINUCLEOTIDE (UNII: 0U46U6E8UK) (NICOTINAMIDE ADENINE DINUCLEOTIDE - UNII:0U46U6E8UK) NICOTINAMIDE ADENINE DINUCLEOTIDE250 mg  in 1 U
    GLUTATHIONE (UNII: GAN16C9B8O) (GLUTATHIONE - UNII:GAN16C9B8O) GLUTATHIONE25 mg  in 1 U
    Inactive Ingredients
    Ingredient NameStrength
    LACTOSE (UNII: J2B2A4N98G)  
    GLUTENIN (UNII: FX065C7O71)  
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:85945-0001-130 U in 1 PATCH; Type 0: Not a Combination Product07/01/2025
    2NDC:85945-0001-28 U in 1 PATCH; Type 0: Not a Combination Product07/01/2025
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    unapproved drug other07/01/2025
    Labeler - Through Medical INC. (134422688)
    Registrant - Through Medical INC. (134422688)
    Establishment
    NameAddressID/FEIBusiness Operations
    Through Medical INC.134422688manufacture(85945-0001)
View All Sections

Find additional resources

(also available in the left menu)

Safety

Report Adverse Events, FDA Safety Recalls, Presence in Breast Milk

Related Resources

Medline Plus, Clinical Trials

More Info on this Drug

Get Label RSS Feed, View NDC Code(s)NEW!